Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 4 , Pages 212-216 , October 2009

Pharmacology of steroids used during epidural steroid injections

  • Vadim Kushnerik, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Vadim Kushnerik, MD, Department of Surgery, New York Downtown Hospital, 170 William Street, New York, NY 10038
  • ,
  • Glen Altman, PharmD
  • ,
  • Paul Gozenput, MD

References 

  1. Bogduk N, Christophidis N, Cherry D. Epidural Use of Steroids in the Management of Back Pain: Report of the Working Party on Epidural Use of Steroids in the Management of Back Pain. In: Canberra, Commonwealth of Australia: National Health and Medical Research Council; 1994;p. 1–76
  2. Hollander JL, Brown EM, Jessar RA, et al. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc. 1951;147:1629–1635
  3. Boswell M, Trescot A, Datta S. Interventional techniques: Evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007;10:7–111
  4. Goebert HW, Jallo SJ, Gardner WJ, et al. Painful radiculopathy treated with epidural injections of procaine and hydrocortisone acetate results in 113 patients. Anesth Analg. 1961;140:130–134
  5. Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician. 2002;5:182–199
  6. Abdi S, Datta S, Trescot AM, et al. Epidural steroids in the management of chronic spinal pain: A systematic review. Pain Physician. 2007;10:185–212
  7. Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. J Am Med Assoc. 1952;149:1542–1543
  8. Jacobs A, Pullan PT, Potter JM, et al. Adrenal suppression following extradural steroids. Anaesthesia. 1983;38:953–956
  9. Kay JK, Findling JW, Raff H. Epidural triamcinolone suppresses the pituitary adrenal axis in human subjects. Anesth Analg. 1994;79:501–505
  10. Tiso RL, Cutler T, Catania JA, et al. Adverse central nervous system sequelae after selective transforaminal block: The role of corticosteroids. Spine J. 2004;4:468–474
  11. Benzon HT, Chew TL, McCarthy RJ, et al. Comparison of the particle sizes of different steroids and the effect of dilution. Anesthesiology. 2007;106:331–338
  12. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. J Am Med Assoc. 2002;287:236–240
  13. Orth DN, Kovacs WJ. The adrenal cortex. In:  Wilson JD,  Foster DW,  Kronenberg HM,  Larsen PR editor. Williams Textbook of Endocrinology. ed 9. Philadelphia, PA: W. B. Saunders; 1998;p. 517–665
  14. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin. 2001;17:25–41
  15. Esteban NV, Loughlin T, Yergey A, et al. Daily cortisol production in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab. 1991;72:39–45
  16. Lamberts SWJ, Bruining HA, DeJong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337:1285–1292
  17. Krasner AS. Glucocorticoid-induced adrenal insufficiency. J Am Med Assoc. 1999;282:671–676
  18. In:  McEvoy GK editors. AHFS 2007 Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2007;
  19. Mikhail GR, Sweet LC, Mellinger RC. Parenteral long-acting corticosteroid effect on hypothalamic pituitary adrenal function. Ann Allerg. 1973;31:337–343
  20. Mikhail GR, Livingood CS, Mellinger RC, et al. Effect of long-acting parenteral corticosteroids on adrenal function. Arch Dermatol. 1969;100:263–268
  21. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In:  Hardman JG,  Molinoff PB,  Ruddon RW editor. Goodman's and Gilman's, The Pharmacological Basis of Therapeutics. ed 9. New York: McGraw-Hill; 1996;p. 1459–1485
  22. Huntoon MA. Complications associated with chronic steroid use. In:  Neal JM,  Rathmell JP editor. Complications in Regional Anesthesia and Pain Medicine. Philadelphia, PA: W. B. Saunders; 2007;p. 331–339
  23. Buckley LM, Marquez M, Hudson JO, et al. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty. J Rheumatol. 1998;25:2195–2202
  24. Nelson D. Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol. 1988;45:804–806
  25. Bogduk N, Cherry D. Epidural corticosteroid agents for sciatica. Med J Aust. 1985;143:402–406
  26. Benzon HT, Gissen AJ, Strichartz GR, et al. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg. 1987;66:553–559
  27. Craig DB, Habib GG. Flaccid paraparesis following obstetrical epidural anesthesia: Possible role of benzyl alcohol. Anesth Analg. 1977;56:219–222
  28. Abram SE, O'Connor TC. Complications associated with epidural steroid injections. Reg Anesth. 1996;212:149–162
  29. Hsu D, Fu P, Gyermek L, et al. Comparison of plasma cortisol and ACTH profile after a single lumbar epidural dose of triamcinolone 40 mg, 80 mg respectively in low back pain patients. Anesth Analg. 1996;82:S191
  30. Ling C, Atkinson PL, Munton CG. Bilateral retinal hemorrhages following epidural injection. Br J Ophthalmol. 1993;77:316–317
  31. Kushner FH, Olson JC. Retinal hemorrhage as a consequence of epidural steroid injection. Arch Ophthalmol. 1995;113:309–313
  32. Brouwers PJAM, Kottnik EJBL, Simon MAM, et al. A cervical anterior spinal artery syndrome after diagnostic blockade of the right C6-nerve root. Pain. 2001;91:397–399
  33. Houten JK, Errico TJ. Paraplegia after lumbosacral nerve root block: Report of three cases. Spine J. 2002;2:70–75
  34. Baker R, Dreyfuss P, Mercer S, et al. Cervical transforaminal injection of corticosteroids into a radicular artery: A possible mechanism for spinal cord injury. Pain. 2003;103:211–215
  35. Rozin L, Rozin R, Koehler SA, et al. Death from transforaminal epidural steroid nerve root block (C7) due to perforation of the left vertebral artery. Am J Forensic Med Pathol. 2003;24:351–355
  36. Huntoon MC, Martin DP. Paralysis after transforaminal epidural injection and previous spinal surgery. Reg Anesth Pain Med. 2004;29:494–495
  37. Karasek M, Bogduk N. Temporary neurologic deficit after cervical transforaminal injection of local anesthetic. Pain Med. 2004;5:202–205
  38. Scanlon GC, Moeller-Bertram T, Romanowsky SM, et al. Cervical transforaminal epidural steroid injections: More dangerous than we think?. Spine. 2007;32:1249–1256
  39. Rathmell JP, April C, Bogduk N. Cervical transforaminal injection of steroids. Anesthesiology. 2004;100:1595–1600
  40. Rathmell JP, Benzon HT. Transforaminal injection of steroid: Should we continue?. [editorial] Reg Anesth Pain Med. 2004;29:397–399
  41. Huntoon MA. Anatomy of the cervical intervertebral foramina: Vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain. 2005;117:104–111
  42. Benzon HT, Chew TL, McCarthy RJ, et al. Comparison of the particle sizes of different steroids and the effect of dilution. Anesthesiology. 2007;106:331–338
  43. Hoeft MA, Rathmell JP, Monsey RD, et al. Cervical transforaminal injection and the radicular artery: Variation in anatomical location within the cervical intervertebral foramina. Reg Anesth Pain Med. 2006;31:270–274
  44. Hsu D, Fu P, Gyermek L, et al. Comparison of plasma cortisol and ACTH profile after a single lumbar epidural dose of triamcinolone 40 mg, 80 mg respectively in low back pain patients. Anesth Analg. 1996;82:S191

PII: S1084-208X(09)00057-3

doi: 10.1053/j.trap.2009.07.004

Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 4 , Pages 212-216 , October 2009